Arsenicosis: Review of recent advances

Journal of Association of Physicians of India

Volumn 58, Issue 10, 2010, Pages 617-629

  Pimparkar, B D ^a   Bhave, Aruna ^b,c  

^a KEM HOSPITAL   (India)

^b GANDHI MEDICAL COLLEGE   (India)

^c Wockhardt Hospitals India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CARCINOGEN;

ANIMAL; ARSENIC POISONING; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; HUMAN; METABOLISM; NEOPLASM; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; RAT; WATER POLLUTANT; WATER SUPPLY;

ANIMALS; ARSENIC; ARSENIC POISONING; CARCINOGENS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES; RATS; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 78049282507     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Health Hazards of the human Environment. WHO, Geneva 1972;174-178.
2. Bogden JB, Klevey LM. Clinical Nutrition of the Essential Trace Elements and Minerals. The Guide for Health Professionals, Humana Press, Totova, New Jersey, USA, 2000.
3. Harvey SC. Heavy metals. In Pharmacological basis of Therapeutics. Editors Goodman LS, Gilman A and Koele GB. McMillan Press, New York, 1975;924-928.
4. Morris JS, Schmid M, Newman S, Scheuer PJ, Sherlock S. Arsenic and noncirrhotic portal hypertension. Gastroenterology 1974;66:86-94.
5. Huch PM, Guillaimo E, Gote J, Légaré A, Lavoir P, Viallet A. Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication. Gastroenterology 1975;68:1270-1277.
6. Guha Mazumder DN, Chakravarthy AK, Ghose A, Gupta JD, Chakraborty DP, Dey SB, et al. Chronic arsenic toxicity from drinking tube well water in rural West Bengal. Bulletin WHO 1988;66:499-504.
7. Guha Mazumder DN, DasGupta J, Chakraborty AK, Chaterjee A, Das D, Chakraborty D. Environmental pollution and chronic arsenicosis in south Calcuta. Bulletin, WHO 1992;70:481-483.
8. Guha Mazumder DN. Treatment of chronic arsenic toxicity as observed in West bengal (editorial). J Indian Med Assoc 1996;94:41-42.
9. Nevens F, Fevery J, Van Steenbergen W, Sciot R, Desmet V, De Groote J. Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol 1990;11:80-5.
10. Santra A, Das Gupta J, De BK, Roy B, Guha Mazumder DN. Hepatic manifestations in chronic arsenic toxicity. Indian J Gastroenterol 1999;18:152-5.
11. Basu AK, Guharay BM. Non cirrhotic portal fbrosis with portal hypertension: Academic Publications, Calcutta - New Delhi 1978;p66, 248, 253.
12. Data DV, Mitra SK, Chhutani PN, Chakravarti RN. Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fbrosis) in India. Gut 1979;20:378-384.
13. Guha Mazumder DN. Chronic arsenic toxicity and human health. Indian J Med Res 2008;128:436-447.
14. Narang AP. Arsenicosis in India. J Toxicol Clin Toxicol 1987;25:287-95.
15. Chautala LS, Khurana VB: Levels of arsenic in alcohol related liver diseases. Drug Alcohol Dependence 1987;19:177-180.
16. International Standards for drinking water. WHO 1971, 3rd Ed. Geneva, WHO quoted by WHO 1972.
17. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008;300:814-22.
18. Uthus EO. Evidence for arsenic essentiality: Environ Geochem Health 1992;14:55-58.
19. Nielsen FH, Uthus ED. Arsenic. In: Friedon E, Ed. Biochemistry of essential ultra trace elements. Plenum, New York 1989;319-340.
20. Uthus EO. Arsenic essentiality and factor afecting its importance. In: Chappel WR, Abernathy CO, Cothern CR, eds. Exposure and Health Science and Technology Leters, Northwood 1994, p. 199-208.
21. Nriagu JO, Davidson CI. Toxic metals in the atmospheres. John Wielly & Sons, New York, London. 1986, p 25, 125-160.
22. Pacyno JN. Emission factors of atmospheric elements in toxic metals in the atmosphere. Edited by Nriagu JO, Davidson 1986;25.
23. Gerhardsson L, Brune D, Nordberg GF, Wester PO. Multielemental assay of tissues of deceased smelter workers and controls. Sci Total Environ 1988;74:97-110.
24. Howard HU. Heavy metal poisoning. In: Harrison's Principles of Internal Medicine. McGraw-Hill Publishing Co., New York. 2001;2493-2594.
25. Liu JX, et al. Poisoning from arsenic containing coal in Guizhan state in China. Environmental Health Perspecitve 2002; 110: (quoted by Santra et al.)
26. Grupe G, Hermann B. Trace elements in environmental history. Proceedings of the symposium. Springer Verlog Berlin, New York, 1987; p 136-137.
27. Davies IJT. The clinical signifcance of the essential biological metals. William Harmann Medical Books Ltd, London, 1972.
28. Schroeder HA. The trace elements and nutrition: some positive and negative aspects. Faber & Faber, London 1973, p 54 & 140.
29. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 1988;8:452-460.
30. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989;130:1123-1132.
31. National Research Council. Arsenic in drinking water. National academic Press. Washington DC, 1999.
32. International Atomic Energy Agency (1980). Elemental analysis of biological materials: Current problems and techniques with special reference to trace elements. IAeA in Vienna, Austria.
33. Bhave AP. Toxic trace elements in cirrhosis. Thesis for MD, Bombay University 1982.
34. Bhivankar NT. Trace Elements in Various Liver Diseases. Thesis for PhD. University of Bombay. 1982
35. Abornathy CO, Doursm ML. Derivatives of inorganic arsenic reference dose. In: Chappel WR, Abornathy CO, Cothern CR, eds. Arsenic exposure and Health Science and Technology Leters, Northwood 1994;295-303.
36. Santra A, Maiti A, Chowdhury A, Guha Mazumder DN. Oxidative stress in liver of mice exposed to arsenic-contaminated water. Indian J Gastroenterol 2000;19:112-115.
37. Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK. Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Toxicol Appl Pharmacol 2007;220:146-155.
38. Dizik M, Christmas JK, Wenaton E. Alternatives in expression and methylation of specifc genes in livers of rats fed a cancer promoting methyl defcient diet. Carcinogenesis 1991;12:1303-1312.
39. Zapisek WF, Cronin GM, Lyn-Cook BD, Poirier LA. The onset of oncogene hypomethylation in the livers of rats fed methyl-defcient, amino acid-defned diets. Carcinogenesis 1992;13:1869-1872.
40. Woods JS, Southern MR. Studies on the etiology of trace metal-induced porphyria: effects of porphyrinogenic metals on coproporphyrinogen oxidase in rat liver and kidney. Toxicol Appl Pharmacol 1989;97:183-190.
41. Beres J. Interactive relations between Cu, FC, Zn, As, Cd & Pb in the liver in sheep after experimental poisoning with copper oxide. Vet Med (Praka) 1989;34:665-674.
42. Buchet JP. Lauwerys R. Study of factors infuencing the in vivo methylation of inorganic arsenic in rats. Toxicol Appl Pharmacol 1987;9:65-74.
43. Aposhian HV. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annual Review Pharmacol Toxicol 1997;27:397-419.
44. Boyer JL. Arsenic: an endothelial cell toxin in the liver? Indian J Gastroenterol 1999;18:141-142.
45. Das S, Santra A, Lahiri S, Guha Mazumder DN. Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol Appl Pharmacol 2005;204:18-26.
46. Ghosh A, Ghatak S, Data S, Dhali GK, Choudhury A, Santra A. Dimethyl arsenic acid induced apoptosis of hepatocytes is mediated through mitochondria. An in-vitro study. Indian J Gastroenterol 2007;26:4-87.
47. Ghatak S, Biswas A, Dhali GK, Choudhury A, Santra A. Death receptor mediated apoptosis in liver of arsenic exposed mice. Indian J Gastroenterol 2007;26:A-86.
48. Mueller PD, Benowit NL. Toxicologic causes of acute abdominal disorders (Review). Emerg Med Clin North Am 1989;7:667-682.
49. Guha Mazumder DN. Hepatology in Kolkata. Indian J Gastroenterol 2007;26:S18-S23.
50. Tello SE. carcinoma of the internal organs and the relationship to arsenical drinking water in the Republic of Argentine. Med Cutan Iberolal Amer 1988;16:147-501.
51. Malhotra SL. Use of BAL in the treatment of arsenical neuropathy. Ind Med Gazete, Vol LXXXVI Aug. 1951.
52. Rahman M, Tondel M, Ahmed SA, et al. Hypertension and arsenic exposure in bangladesh. Hypertension 1999;33:74-78.
53. Navas-Acien A, Sharret AR, Silbergeld EK, Schwart BS, Nachman KE, Burke TA, et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence (Review). Am J Epidemiol 2005;162:1037-1049.
54. Speter EE. Environmental lung disease: occupational acceptance and pulmonary disease. In: Harrison's Principles of Internal Medicine, p 1471, McGraw Hill Publishing, New York, 2001.
55. Liu SK, Alher CM, Lippari I, Naldren C, Hei IK. Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity. Proc Natl Acad Sci 2001;98:1643-1648.
56. Liu MM, Kuo FL, Hwaugy YH, Chen CA. Dose response relation between arsenic concentration in well water and mortality from cancer and vascular diseases. Amer J Epidemiol 1989:130:1123-1132.
57. Longnecker MP, Daniel JL. Environmental contamination as etiologic factors in diabetes. Environ Health Prospect 2000;109:871-876.
58. Rahman M, Wingren G, Axelson O. Diabetes mellitus among Swedish art glass workers--an efect of arsenic exposure? Scand J Work Environ Health 1996;22:146-149
59. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 1994;139:484-492.
60. Tseng CN. the potential biological mechanisms of arsenic-induced diabetes mellitus (Review). Toxicol Appl Pharmacol 2004;197:67-83.
61. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence (Review). Environ Health Perspect 2006;114:641-648.
62. National Health and Nutrition. Examination survey (NHAES). Quoted by Navas-Acien A, et al. 2008.
63. Navas-Acien A, Guallar E. Measuring arsenic exposure, metabolism, and biological efects: the role of urine proteomics. Toxicol Sci 2008;106:1-4.
64. Braman RS, Foreback CC. Methylated forms of arsenic in the environment. Science 1973;182:1247-1249.
65. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003;3:710-720.
66. Hegedus CM, Skibola CF, Warner M, Skibola DR, Alexander D, Lim S, et al. Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci 2008;106:74-82.